As mentioned before, in humans, prion strain variation and the polymorphic codon 129 of PRNP are two of the major biological determinants of the clinicopathological phenotype of the disease and an individual’s susceptibility to develop prion diseases. This evidence concerns the gene PRNP and prion disease.